NCT00002818View on ClinicalTrials.gov

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 1995

Primary Completion Date

February 28, 2001

Study Completion Date

February 28, 2001

Conditions
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

cytarabine

DRUG

deoxycytidine

Trial Locations (1)

23298-0037

Massey Cancer Center, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Virginia Commonwealth University

OTHER